CIK: 0001560009
Total reported value
$141.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 67.15% | -0.16% | -0.35% | |
| 2 | VCYT | Veracyte INC | Stock-Other | 11.19% | — | -50.00% | |
| 3 | 2JQ | Gritstone Bio INC | Stock-Other | 10.37% | — | — | |
| 4 | BOLDEUR | Audentes Therapeutics INC | Stock-Other | 6.02% | — | — | |
| 5 | OCUL | Ocular Therapeutix INC | Stock-Other | 2.61% | — | — | |
| 6 | ✓ | Second Sight Med Prods INC | Stock-Other | 1.43% | — | — | |
| 7 | CBAYUSD | Cymabay Therapeutics INC | Stock-Other | 1.08% | — | — | |
| 8 | CLVSEUR | Clovis Oncology INC | Stock-Other | 0.15% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CRSP | CRISPR Therapeutics AG | +8.8% | -0.35% | Trim |
| 2 | ✓ | Second Sight Med Prods INC | +0.4% | — | Unchanged |
| 3 | 2JQ | Gritstone Bio INC | +0.3% | — | Unchanged |
| 4 | CBAYUSD | Cymabay Therapeutics INC | -0.1% | — | Unchanged |
| 5 | BOLDEUR | Audentes Therapeutics INC | -0.1% | — | Unchanged |
| 6 | OCUL | Ocular Therapeutix INC | -0.2% | — | Unchanged |
| 7 | CLVSEUR | Clovis Oncology INC | -0.3% | — | Unchanged |
| 8 | VCYT | Veracyte INC | -8.8% | -50.00% | Trim |
| 9 | ✓ | Opgen, Inc. | — | EXIT | Sold out |